beqalzi
Beqalzi (Sonrotoclax) is a medication supplied as a tablet.
Sonrotoclax · by Beone Medicines USA
Key facts
- Active ingredient
- Sonrotoclax
- Form
- Tablet
- Strength
- Sonrotoclax 1MG · Sonrotoclax 20MG · Sonrotoclax 5MG · Sonrotoclax 80MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Beone Medicines USA
- FDA application
- NDA220711
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- Is there a coupon or discount for Beqalzi?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Beqalzi. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Beqalzi?
- Beqalzi is marketed by Beone Medicines USA. You can see Beone Medicines USA's full profile, rating, and other products on pharmaranks.
- Is Beqalzi a brand-name or generic drug?
- Beqalzi is a brand-name product with the active ingredient Sonrotoclax.
- Is Beqalzi available over the counter?
- No. Beqalzi is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Beqalzi come in?
- Beqalzi is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Beqalzi FDA-registered?
- Beqalzi is on record with the U.S. FDA under application number NDA220711. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about SONROTOCLAX
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 10 reports naming SONROTOCLAX — the active ingredient in Beqalzi, and the FDA flagged 90% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- acute kidney injury3 reports
- pneumonia2 reports
- rhinovirus infection2 reports
- acute myeloid leukaemia1 reports
- adverse event1 reports
- anaemia1 reports
- arrhythmia1 reports
- atrial flutter1 reports
Read these as a signal, not a rate. A report does not mean SONROTOCLAX caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
benzamycin
Benzoyl Peroxide and Erythromycin
colazal
Balsalazide Disodium
cuprimine
Penicillamine
mysoline
Primidone
retin-a
Tretinoin
tolak
Fluorouracil
Compare Beqalzi head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
beqalzi
New